Moreover, the increased Src activation has been reported as a further mechanism of acquired resistance to different MKIs by activating RET downstream effector ERK1/2 in RET-rearranged lung adenocarcinoma [106]. The gene discussed is RET; the disease is lung adenocarcinoma.